| Biomarker ID | 1709 |
| PMID | 26126436 |
| Year | 2015 |
| Biomarker | hsv1-miR-H18 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue+Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa (Tissue) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Benign prostatic hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | For Validation cohort 191 PCa with 143 controls were selected. Urine samples were analysed from this data set. Final Validation Cohort consisted of tissue samples from 46 patients with PCa and 104 with No PCa |
| Senstivity | NA |
| Specificity | Urine: 74.1%; Tissue:67.3% |
| AUC | Urine: 0.772; Tissue: 0.639 |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | Values in regulatation column are presented as median (interquartile range; × 102 copies/miRNA concentration) |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |